Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Peribulbar Block in Cataract Surgery
NCT06784843Completed
- Sponsor
- Suez Canal University
- Start
- Dec 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in cataract (2 arms), sponsored by Suez Canal University. Primary endpoint: Onset of motor block. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT06784843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784843.